13F HOLDINGS REPORT
Soleus Capital Management, L.P.
Quarter ended Q3 2025 · Filed November 14, 2025 · Accession 0001802630-25-000018
Total Value
$1.99B
Positions
88
Other Managers
0
Confidential Omitted
No
Holdings (88)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | KRYSTAL BIOTECH INC | KRYS | 1,018,831 | $179.9M | 9.05% |
| 2 | TG THERAPEUTICS INC | TGTX | 3,844,731 | $138.9M | 6.99% |
| 3 | NOVOCURE LTD | NVCR | 9,644,872 | $124.6M | 6.27% |
| 4 | SPDR SERIES TRUST | 78464A870 | 1,150,000 | $115.2M | 5.80% |
| 5 | ELEVANCE HEALTH INC FORMERLY | ELV | 259,650 | $83.9M | 4.22% |
| 6 | BETA BIONICS INC | BBNX | 3,870,158 | $76.9M | 3.87% |
| 7 | UNITED THERAPEUTICS CORP DEL | UTHR | 150,000 | $62.9M | 3.17% |
| 8 | TERNS PHARMACEUTICALS INC | TERN | 8,127,100 | $61.0M | 3.07% |
| 9 | CELCUITY INC | CELC | 1,178,860 | $58.2M | 2.93% |
| 10 | INSPIRE MED SYS INC | 457730109 | 728,188 | $54.0M | 2.72% |
| 11 | TWIST BIOSCIENCE CORP | TWST | 1,866,234 | $52.5M | 2.64% |
| 12 | ARGENX SE | ARGX | 69,426 | $51.2M | 2.58% |
| 13 | ORGANOGENESIS HLDGS INC | ORGO | 12,131,699 | $51.2M | 2.58% |
| 14 | BIOMARIN PHARMACEUTICAL INC | BMRN | 890,304 | $48.2M | 2.43% |
| 15 | CIDARA THERAPEUTICS INC | 171757206 | 493,811 | $47.3M | 2.38% |
| 16 | PRAXIS PRECISION MEDICINES I | PRAX | 859,166 | $45.5M | 2.29% |
| 17 | AMICUS THERAPEUTICS INC | FOLD | 4,690,000 | $37.0M | 1.86% |
| 18 | INDIVIOR PLC | INDV | 1,466,000 | $35.3M | 1.78% |
| 19 | MADRIGAL PHARMACEUTICALS INC | MDGL | 68,336 | $31.3M | 1.58% |
| 20 | ANI PHARMACEUTICALS INC | ANIP | 340,243 | $31.2M | 1.57% |
| 21 | SYNDAX PHARMACEUTICALS INC | SNDX | 2,012,110 | $31.0M | 1.56% |
| 22 | AXOGEN INC | AXGN | 1,726,553 | $30.8M | 1.55% |
| 23 | NEUROPACE INC | NPCE | 2,957,957 | $30.5M | 1.54% |
| 24 | GRIFOLS S A | GIKLY | 2,500,000 | $24.9M | 1.25% |
| 25 | GERON CORP | GERN | 17,290,000 | $23.7M | 1.19% |
| 26 | NURIX THERAPEUTICS INC | NRIX | 2,422,833 | $22.4M | 1.13% |
| 27 | INTEGRA LIFESCIENCES HLDGS C | IART | 1,440,818 | $20.6M | 1.04% |
| 28 | NEUROCRINE BIOSCIENCES INC | NBIX | 138,000 | $19.4M | 0.98% |
| 29 | ANAPTYSBIO INC | ANABV | 626,040 | $19.2M | 0.97% |
| 30 | EDAP TMS S A | EDAP | 7,309,254 | $16.7M | 0.84% |
| 31 | PHARVARIS N V | PHVS | 647,052 | $16.1M | 0.81% |
| 32 | VERICEL CORP | VCEL | 497,953 | $15.7M | 0.79% |
| 33 | C4 THERAPEUTICS INC | CCCC | 7,053,942 | $15.7M | 0.79% |
| 34 | BELITE BIO INC | BLTE | 210,000 | $15.5M | 0.78% |
| 35 | VERACYTE INC | VCYT | 422,055 | $14.5M | 0.73% |
| 36 | RAPT THERAPEUTICS INC | 75382E208 | 537,903 | $13.9M | 0.70% |
| 37 | UROGEN PHARMA LTD | URGN | 679,000 | $13.5M | 0.68% |
| 38 | STAAR SURGICAL CO | STAA | 500,000 | $13.4M | 0.68% |
| 39 | SIONNA THERAPEUTICS INC | SION | 413,500 | $12.2M | 0.61% |
| 40 | CG ONCOLOGY INC | CGON | 290,000 | $11.7M | 0.59% |
| 41 | UNIQURE NV | QURE | 200,000 | $11.7M | 0.59% |
| 42 | QUIDELORTHO CORP | QDEL | 375,000 | $11.0M | 0.56% |
| 43 | MIRUM PHARMACEUTICALS INC | MIRM | 148,696 | $10.9M | 0.55% |
| 44 | ADMA BIOLOGICS INC | ADMA | 738,000 | $10.8M | 0.54% |
| 45 | INHIBIKASE THERAPEUTICS INC | IKT | 6,325,000 | $10.2M | 0.52% |
| 46 | GLOBUS MED INC | GMED | 176,000 | $10.1M | 0.51% |
| 47 | GSK PLC | GLAXF | 220,000 | $9.5M | 0.48% |
| 48 | RIGEL PHARMACEUTICALS INC | RIGL | 330,010 | $9.3M | 0.47% |
| 49 | EVOLUS INC | EOLS | 1,450,000 | $8.9M | 0.45% |
| 50 | VERASTEM INC | VSTM | 935,909 | $8.3M | 0.42% |
| 51 | ARCELLX INC | ACLX | 100,000 | $8.2M | 0.41% |
| 52 | NUVALENT INC | NUVL | 88,000 | $7.6M | 0.38% |
| 53 | ALNYLAM PHARMACEUTICALS INC | ALNY | 15,250 | $7.0M | 0.35% |
| 54 | JADE BIOSCIENCES INC | JBIO | 796,744 | $6.9M | 0.35% |
| 55 | LB PHARMACEUTICALS INC | LBRX | 400,000 | $6.3M | 0.32% |
| 56 | OLEMA PHARMACEUTICALS INC | OLMA | 619,874 | $6.1M | 0.31% |
| 57 | KINIKSA PHARMACEUTICALS INTL | G52694109 | 150,000 | $5.8M | 0.29% |
| 58 | ESTABLISHMENT LABS HLDGS INC | ESTA | 139,512 | $5.7M | 0.29% |
| 59 | MBX BIOSCIENCES INC | MBX | 275,000 | $4.8M | 0.24% |
| 60 | ERASCA INC | ERAS | 2,162,162 | $4.7M | 0.24% |
| 61 | ETON PHARMACEUTICALS INC | ETON | 200,000 | $4.3M | 0.22% |
| 62 | CERIBELL INC | CBLL | 360,000 | $4.1M | 0.21% |
| 63 | HARROW INC | HROW | 85,498 | $4.1M | 0.21% |
| 64 | FRACTYL HEALTH INC | GUTS | 2,500,000 | $4.0M | 0.20% |
| 65 | JASPER THERAPEUTICS INC | JSPRW | 1,494,420 | $3.6M | 0.18% |
| 66 | INSPIREMD INC | NSPR | 1,470,934 | $3.5M | 0.18% |
| 67 | AKERO THERAPEUTICS INC | 00973Y108 | 71,000 | $3.4M | 0.17% |
| 68 | IDEAYA BIOSCIENCES INC | IDYA | 100,000 | $2.7M | 0.14% |
| 69 | TANGO THERAPEUTICS INC | TNGX | 300,000 | $2.5M | 0.13% |
| 70 | CRESCENT BIOPHARMA INC. | CBIO | 200,000 | $2.4M | 0.12% |
| 71 | RAPPORT THERAPEUTICS INC | RAPP | 80,000 | $2.4M | 0.12% |
| 72 | ORTHOPEDIATRICS CORP | KIDS | 128,000 | $2.4M | 0.12% |
| 73 | IOVANCE BIOTHERAPEUTICS INC | IOVA | 976,707 | $2.1M | 0.11% |
| 74 | CALCIMEDICA INC | CALC | 683,904 | $2.1M | 0.11% |
| 75 | VISTAGEN THERAPEUTICS INC | VTGN | 550,000 | $2.0M | 0.10% |
| 76 | MANNKIND CORP | MNKD | 300,000 | $1.6M | 0.08% |
| 77 | IMMUNIC INC | IMUX | 1,580,007 | $1.4M | 0.07% |
| 78 | ADVERUM BIOTECHNOLOGIES INC | 00773U207 | 287,246 | $1.3M | 0.07% |
| 79 | LIQUIDIA CORPORATION | LQDA | 50,000 | $1.1M | 0.06% |
| 80 | ESSA PHARMA INC | 29668H708 | 4,362,026 | $833,147 | 0.04% |
| 81 | MYOMO INC | MYO | 704,275 | $628,213 | 0.03% |
| 82 | MEREO BIOPHARMA GROUP PLC | MREO | 299,711 | $617,405 | 0.03% |
| 83 | TECTONIC THERAPEUTIC INC | TECX | 25,000 | $392,250 | 0.02% |
| 84 | INSMED INC | INSM | 2,550 | $367,226 | 0.02% |
| 85 | SEPTERNA INC | SEPN | 18,260 | $343,471 | 0.02% |
| 86 | KODIAK SCIENCES INC | KOD | 19,644 | $321,572 | 0.02% |
| 87 | TREVI THERAPEUTICS INC | TRVI | 25,000 | $228,750 | 0.01% |
| 88 | DELCATH SYS INC | DCTH | 10,000 | $107,500 | 0.01% |